Crossmark

GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation

Crossref DOI link: https://doi.org/10.1038/s41409-023-02033-0

Published Online: 2023-08-09

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dachy, François https://orcid.org/0000-0001-9981-2508
Furst, Sabine

Calmels, Boris https://orcid.org/0000-0002-1684-6030
Pagliardini, Thomas

Harbi, Samia

Bouchacourt, Benjamin https://orcid.org/0000-0003-3908-2595
Calleja, Anne

Lemarie, Claude

Collignon, Aude

Morel, Guillaume

Legrand, Faezeh

Bekrieva, Elena

Granata, Angela

Weiller, Pierre Jean https://orcid.org/0009-0007-8120-7781
Chabannon, Christian https://orcid.org/0000-0002-3755-4889
Schiano, Jean Marc https://orcid.org/0000-0001-9923-4808
Vey, Norbert https://orcid.org/0000-0001-7027-040X
Blaise, Didier https://orcid.org/0000-0002-5684-9447
Devillier, Raynier https://orcid.org/0000-0002-4045-8310
License Information

Text and Data Mining valid from 2023-08-09

Version of Record valid from 2023-08-09
More Information

Article History

Received: 2 September 2022

Revised: 1 June 2023

Accepted: 3 July 2023

First Online: 9 August 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below